Bigfoot Unity® Demonstrates Strong Glycemic Control Among People with Type 2 Diabetes in Real-World Retrospective Analysis
Data from the real-world retrospective analysis suggests that, for people on multiple daily injections (MDI) of insulin, using the Bigfoot Unity System has the potential for rapid and durable improvement in glycemic control.
- Data from the real-world retrospective analysis suggests that, for people on multiple daily injections (MDI) of insulin, using the Bigfoot Unity System has the potential for rapid and durable improvement in glycemic control.
- The First Real-World Experience with Bigfoot Unity A 3-Month Retrospective Analysis analyzed 49 people with diabetes with an average age of 60.3 years.
- The study found strong glucose control at three months of use of Bigfoot Unity.
- Bigfoot Biomedical was founded by a team of people with personal connections to Type 1 and Type 2 diabetes.